Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
|
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [21] Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers A Comparison of Outcomes in Patients With COVID-19
    Kalra, Ankur
    Hawkins, Edward S.
    Nowacki, Amy S.
    Jain, Vardhmaan
    Milinovich, Alex
    Saef, Joshua
    Thomas, George
    Gebreselassie, Surafel K.
    Karnik, Sadashiva S.
    Jehi, Lara
    Young, James B.
    Svensson, Lars G.
    Chung, Mina K.
    Mehta, Neil
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (10): : E007115
  • [22] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [23] Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
    Mekary, Wissam
    Fares, Souha
    Abdulhai, Farah
    Massoud, Gaelle
    Refaat, Marwan
    Mericskay, Mathias
    Booz, George W.
    Zouein, Fouad A.
    HELIYON, 2023, 9 (09)
  • [24] The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
    Harky, Amer
    Chor, Cheryl Yan Ting
    Nixon, Henry
    Jeilani, Milad
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2021, 22 (01)
  • [25] Impact of Angiotensin Converting Enzyme Inhibitors/angiotensin Receptor Blockers on Mortality and Severity of Covid-19 Pneumonia
    Aggarwal, Ankita
    Jain, Anubhav
    Goel, Mishita
    Tusha, Jurgena
    Khanam, Verisha
    Bidhan, Sourabh
    Khan, Ameer
    Dhawan, Monica
    Tegeltija, Vesna
    Kumar, Sarwan
    CIRCULATION, 2020, 142
  • [26] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [27] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
    Cure, Erkan
    Cure, Medine Cumhur
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 349 - 350
  • [28] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Ci Tian
    Nan Li
    Yi Bai
    Han Xiao
    Shu Li
    Qing-Gang Ge
    Ning Shen
    Qing-Bian Ma
    World Journal of Clinical Cases, 2021, 9 (01) : 47 - 60
  • [29] Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
    Tian, Ci
    Li, Nan
    Bai, Yi
    Xiao, Han
    Li, Shu
    Ge, Qing-Gang
    Shen, Ning
    Ma, Qing-Bian
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (01) : 47 - 60
  • [30] Association of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and Covid-19 Infection Among Patients With Hypertension
    An, Jaejin
    Wei, Rong
    Zhou, Hui
    Luong, Tiffany
    Liu, Ran
    Gould, Michael K.
    Mefford, Matthew
    Harrison, Teresa N.
    Creekmur, Beth
    Lee, Ming-Sum
    Sim, John J.
    Brettler, Jeffrey W.
    Martin, John P.
    Ong, Angeline L.
    Reynolds, Kristi
    CIRCULATION, 2020, 142
12345